Clinical Trial Update: Immune Modulation With PRaG-1 Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating immune modulation with PRaG-1 in cancer; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Solid Tumor

Drugs mentioned

• PRaG-1 (PRaG-1)

Snippet

Sponsor: Second Affiliated Hospital of Soochow University | Conditions: Cancer, Solid Cancer | Phase 2 | Status: NOT_YET_RECRUITING